Works by Grossmann, Kenneth

Results: 21

Erratum to: Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme.

Published in:

2013

By:

Grossmann, Kenneth;
Colman, Howard;
Akerley, Wallace;
Glantz, Michael;
Matsuoko, Yuko;
Beelen, Andrew;
Yu, Margaret;
Groot, John;
Aiken, Robert;
Olson, Jeffrey;
Evans, Brent;
Jensen, Randy

Publication type:

Correction Notice

Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme.

Published in:

Journal of Neuro-Oncology, 2012, v. 110, n. 2, p. 257, doi. 10.1007/s11060-012-0964-7

By:

Grossmann, Kenneth;
Colman, Howard;
Akerley, Wallace;
Glantz, Michael;
Matsuoko, Yuko;
Beelen, Andrew;
Yu, Margaret;
Groot, John;
Aiken, Robert;
Olsen, Jeffery;
Evans, Brent;
Jensen, Randy

Publication type:

Article

LITESPARK-024: A randomized phase 1/2 study of belzutifan with or without palbociclib for previously treated advanced renal cell carcinoma.

Published in:

Oncologist, 2023, v. 28, p. S11, doi. 10.1093/oncolo/oyad216.017

By:

McDermott, David F;
Peer, Avivit;
Agarwal, Neeraj;
Atkins, Michael B;
Cornell, Jerry;
Perini, Rodolfo F;
Grossmann, Kenneth F;
Gurney, Howard

Publication type:

Article

Real‐world survival of patients with advanced BRAF V600 mutated melanoma treated with front‐line BRAF/MEK inhibitors, anti‐PD‐1 antibodies, or nivolumab/ipilimumab.

Published in:

Cancer Medicine, 2019, v. 8, n. 18, p. 7637, doi. 10.1002/cam4.2625

By:

Moser, Justin C.;
Chen, Danli;
Hu‐Lieskovan, Siwen;
Grossmann, Kenneth F.;
Patel, Shiven;
Colonna, Sarah V.;
Ying, Jian;
Hyngstrom, John R.

Publication type:

Article

Clinical outcomes associated with evolving treatment modalities and radiation techniques for base-of-tongue carcinoma: thirty years of institutional experience.

Published in:

Cancer Medicine, 2015, v. 4, n. 5, p. 651, doi. 10.1002/cam4.364

By:

Chen, Leechuan Andy;
Anker, Christopher J.;
Hunt, Jason P.;
Buchmann, Luke O.;
Grossmann, Kenneth F.;
Boucher, Kenneth;
Fang, Li‐Ming Christine;
Shrieve, Dennis C.;
Hitchcock, Ying J.

Publication type:

Article

Comparison of acute toxicity and mortality after two different dosing regimens of high-dose interleukin-2 for patients with metastatic melanoma.

Published in:

Targeted Oncology, 2014, v. 9, n. 1, p. 63, doi. 10.1007/s11523-013-0276-7

By:

Alwan, Laura;
Grossmann, Kenneth;
Sageser, Daniel;
Atta, Joan;
Agarwal, Neeraj;
Gilreath, Jeffrey

Publication type:

Article

Evaluation of the effect of dabrafenib and metabolites on QTc interval in patients with <italic>BRAF</italic> V600–mutant tumours.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 4, p. 764, doi. 10.1111/bcp.13488

By:

Nebot, Noelia;
Arkenau, Hendrik‐Tobias;
Infante, Jeffrey R.;
Chandler, Jason C.;
Weickhardt, Andrew;
Lickliter, Jason D.;
Sarantopoulos, John;
Gordon, Michael S.;
Mak, Gabriel;
St‐Pierre, Annie;
Tang, Lihua;
Mookerjee, Bijoyesh;
Carson, Stanley W.;
Hayes, Siobhan;
Grossmann, Kenneth F.

Publication type:

Article

Long-term survival as a treatment benchmark in melanoma: latest results and clinical implications.

Published in:

Therapeutic Advances in Medical Oncology, 2015, v. 7, n. 3, p. 181, doi. 10.1177/1758834015572284

By:

Grossmann, Kenneth F.;
Margolin, Kim

Publication type:

Article

Treatment-related determinants of survival in early-stage (T1-2N0M0) oral cavity cancer: A population-based study.

Published in:

Head & Neck, 2017, v. 39, n. 5, p. 876, doi. 10.1002/hed.24679

By:

Sowder, Justin C.;
Cannon, Richard B.;
Buchmann, Luke O.;
Hunt, Jason P.;
Hitchcock, Ying;
Lloyd, Shane;
Grossmann, Kenneth F.;
Monroe, Marcus M.

Publication type:

Article

Comparative effectiveness of second-line ipilimumab vs. nivolumab in combination with ipilimumab in patients with advanced melanoma who received frontline anti-PD-1 antibodies.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 555, doi. 10.1177/1078155220924719

By:

Baron, Kelsey;
Moser, Justin C;
Patel, Shiven;
Grossmann, Kenneth F;
Colonna, Sarah V;
Hyngstrom, John R

Publication type:

Article

Extension of overall survival beyond objective responses in patients with metastatic renal cell carcinoma treated with high-dose interleukin-2.

Published in:

Cancer Immunology, Immunotherapy, 2016, v. 65, n. 8, p. 941, doi. 10.1007/s00262-016-1854-1

By:

Stenehjem, David;
Toole, Michael;
Merriman, Joseph;
Parikh, Kinjal;
Daignault, Stephanie;
Scarlett, Sarah;
Esper, Peg;
Skinner, Katherine;
Udager, Aaron;
Tantravahi, Srinivas;
Gill, David;
Straubhar, Alli;
Agarwal, Archana;
Grossmann, Kenneth;
Samlowski, Wolfram;
Redman, Bruce;
Agarwal, Neeraj;
Alva, Ajjai

Publication type:

Article

A phase 2 study of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.

Published in:

2016

By:

Jimeno, Antonio;
Posner, Marshall R.;
Wirth, Lori J.;
Saba, Nabil F.;
Cohen, Roger B.;
Popa, Elizabeta C.;
Argiris, Athanassios;
Grossmann, Kenneth F.;
Sukari, Ammar;
Wilson, Dawn;
Zhang, Xiaosha;
Sun, Jade;
Glasser, Chad;
Attie, Kenneth M.;
Sherman, Matthew L.;
Pandya, Susan S.;
Weiss, Jared

Publication type:

journal article

Advances in Adjuvant Therapy for the Treatment of High-risk Melanoma.

Published in:

Oncology & Hematology Review, 2013, v. 9, n. 2, p. 132, doi. 10.17925/ohr.2013.09.2.132

By:

Grossmann, Kenneth F.;
Christiansen, Shelley

Publication type:

Article

Granulomatous and Sarcoid-like Immune-Related Adverse Events following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials and a Literature Review.

Published in:

Cancers, 2023, v. 15, n. 9, p. 2561, doi. 10.3390/cancers15092561

By:

Eljilany, Islam;
Noor, Arish;
Paravathaneni, Mahati;
Yassine, Ibrahim;
Lee, Sandra J.;
Othus, Megan;
Moon, James;
Kirkwood, John M.;
Sondak, Vernon K.;
Ribas, Antoni;
Grossmann, Kenneth F.;
Tarhini, Ahmad A.

Publication type:

Article

Local control after stereotactic radiosurgery for brain metastases in patients with melanoma with and without BRAF mutation and treatment.

Published in:

Journal of Neurosurgery, 2015, v. 123, n. 2, p. 395, doi. 10.3171/2014.9.jns141425

By:

Ly, David;
Bagshaw, Hilary P.;
Anker, Christopher J.;
Tward, Jonathan D.;
Grossmann, Kenneth F.;
Jensen, Randy L.;
Shrieve, Dennis C.

Publication type:

Article

Sentinel Lymph Node Biopsy for Melanoma in Pregnant Women.

Published in:

Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2013, v. 20, n. 2, p. 689, doi. 10.1245/s10434-012-2633-7

By:

Andtbacka, Robert;
Donaldson, Matthew;
Bowles, Tawnya;
Bowen, Glen;
Grossmann, Kenneth;
Khong, Hung;
Grossman, Douglas;
Anker, Christopher;
Florell, Scott;
Bowen, Anneli;
Duffy, Keith;
Leachman, Sancy;
Noyes, R.

Publication type:

Article

Adjuvant Treatment For Patients With Surgically Resected Advanced-Stage Melanoma.

Published in:

Clinical Advances in Hematology & Oncology, 2015, v. 13, n. 10, p. 633

By:

Grossmann, Kenneth F.

Publication type:

Article

Molecular testing in malignant melanoma.

Published in:

Diagnostic Cytopathology, 2012, v. 40, n. 6, p. 503, doi. 10.1002/dc.22810

By:

Grossmann, Allie H.;
Grossmann, Kenneth F.;
Wallander, Michelle L.;
Layfield, Lester J.

Publication type:

Article

The Small GTPase ARF6 Stimulates β-Catenin Transcriptional Activity During WNT5A-Mediated Melanoma Invasion and Metastasis.

Published in:

Science Signaling, 2013, v. 6, n. 265, p. 1, doi. 10.1126/scisignal.2003398

By:

Grossmann, Allie H.;
Jae Hyuk Yoo;
Clancy, James;
Sorensen, Lise K.;
Sedgwick, Alanna;
Zongzhong Tong;
Ostanin, Kirill;
Rogers, Aaron;
Grossmann, Kenneth F.;
Tripp, Sheryl R.;
Thomas, Kirk R.;
D'Souza-Schorey, Crislyn;
Odelberg, Shannon J.;
Li, Dean Y.

Publication type:

Article

Assessment of the drug interaction potential and single- and repeat-dose pharmacokinetics of the BRAF inhibitor dabrafenib.

Published in:

Journal of Clinical Pharmacology, 2015, v. 55, n. 4, p. 392, doi. 10.1002/jcph.437

By:

Suttle, A. Benjamin;
Grossmann, Kenneth F.;
Ouellet, Daniele;
Richards‐Peterson, Lauren E.;
Aktan, Gursel;
Gordon, Michael S.;
LoRusso, Patricia M.;
Infante, Jeffrey R.;
Sharma, Sunil;
Kendra, Kari;
Patel, Manish;
Pant, Shubham;
Arkenau, Hendrik‐Tobias;
Middleton, Mark R.;
Blackman, Samuel C.;
Botbyl, Jeff;
Carson, Stanley W.

Publication type:

Article

Comparative-effectiveness of pembrolizumab vs. nivolumab for patients with metastatic melanoma.

Published in:

Acta Oncologica, 2020, v. 59, n. 4, p. 434, doi. 10.1080/0284186X.2020.1712473

By:

Moser, Justin C.;
Wei, Guo;
Colonna, Sarah V.;
Grossmann, Kenneth F.;
Patel, Shiven;
Hyngstrom, John R.

Publication type:

Article